Pneumonia Flashcards

1
Q

What is pneumonia?

A
  • Inflammation of one or both lungs
    • Commonly bacterial or viral cause
    • Fungi, parasites or non-infectoius
    • Alveoli filled with fluid or pus
    • Infiltrates observed via x-ray
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the symptoms of pneumonia?

A
  • Dry or productive cough (phlegm)
  • Difficulty breathing
  • Increased respiratory rate
  • Chest pain on coughing or breathing
  • Fever, sweating or chills
    • Depending on the nature of the organism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why is pneumonia a global health problem?

A

Every year, it kills 1 million children under 5

One of the leading causes of death in young children (about 18% of deaths in U5s, which is worse than diarrhoeal diseases)

A number of bacteria, viruses and fungi cause pneumonia

Healthcare access, malnutrition HIV and indoor air pollution

S.pneumoniae causes 40% of all pneumonia and is a vaccine preventable disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the GAPP project?

A

To protecy, prevent and treat all forms of pneumonia

Reduce the risk of pneumonia in the environment

Avoid illnesses from developing

Improved care for the sick

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the burden of disease with regards to pneumonia?

A
  • Burden of disease is either in the very young or the very old
    • Therefore, the burden of disease is present in the U5s or the over 70s
    • This is because either the immune system has not developed fully, or the immune system is weakened
  • When looking at the death rate pneumonia, you can tell that it is not equitably spread
    • The continents/regions with the largest death rates of pneumonia is subsaharan Africa, India, microasia and south America

When observing the deathrate from pneumonia for children and the gdp per capita, you can see that poorer countries particularly in SSA and southern Asia have the greatest death rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the child deaths by risk factor?

A
  • Our world in data suggests that child wasting is one of the largest contributors for childhood pneumonia
  • Some of the risk factors include:
    • Child wasting
    • Indoor air pollution and solid fuels
    • Low birth weight
    • No access to handwashing facility
    • Short gestation
    • Child stunting
    • Child underweight
    • Non-exclusive breastfeeding
    • Lower respiratory tract infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is S.pneumoniae ?

A
  • GRAM +VE cocci: pneumococcus
  • Polysaccharide capsule is the key virulence factor
    • This is a key characteristic which interferes with the host’s immune system
  • Over 90 different serotypes due to capsule structure
  • You can observe budding entities in electron microscopy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the carriage and disease aspect of S.pneumoniae?

A
  • Carriage and invasive disease
    • Colonises nasopharynx for carriage in healthy individuals
    • This may develop into a number of different diseases like
      • Otitis media
      • Pneumonia
      • Meningitis
      • Septicaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the treatment and protection of pneumonia?

A
  • There are a range of antibiotics available and associated resistance in antibiotics
  • There are polysaccharide (PPV) AND conjugate (pcv) vaccines in use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the different types of vaccines available for pneumonia?

A
  • Polysaccharide vaccine-PPV23
    • There are 23 serotypes and a capsule polysaccharide [Pneumovax-23 produced by Merck]
      • This vaccine will protect against 23 serotypes
    • Mainly used in elderly, poor immune response in children
  • Pneumococcal conjugate vaccine (PCV7, PCV10, PCV13)
    • 7 or 13 pneumococcal serotypes [Prevnar-7/13 produced by Pfizer)
    • 10 serotypes, H.influenzae protein conjugate [Synflorix produced by GSK)
    • The PCV 7, PCV10 & PCV13 are extensively used for childhood immunisation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the new pneumonia vaccines that are being developed today?

A
  • Protein vaccines based on universal protein antigens
    • Vaccines against all serotypes
  • Inactivated pneumococcal whole cell killed vaccine
    • Cheap to make more proteins involved
  • Capsule polysaccharideàthe coating has been conjugated ->improved immunogenity-> more expensive process
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the relationship between transmission, carriage and disease in pneumonia

A
  • There is a relationship between the nasopharyngeal transmission, carriage and disease.
  • Transmission and carriage are related to each other.
  • You could cause transmission of the S.pneumoniae and this could lead to carriage (vice versa)
  • Carriage and disease are related to each other. This is only in one direction (you cannot revert disease back into carriage because you already harbour the disease causing organism)
    • Under certain circumstances can carriage develop into active disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the nasopharyngeal transmission of S.pneumoniae

A
  • New hosts
  • Replacement
    • MOUSE MODEL:
    • Influenza A virus (IAV) coinfection!
    • Toll-like receptor 2 (TLR2)-deficiency, which is associated with an increased viral load (IAV) and, subsequently, greater inflammation, results in higher rates of transmission, and this effect is specific to the index mice (transmission of
  • Competition
  • Confounders (like if you live in more cramped conditions)
    • Nasal inflammation in response to infection with respiratory viruses like influenza a modulates expression of proinflammatory cytokines,
    • upregulates the epithelial receptors used for S.pneumoniae adherance.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the nasopharyngeal disease that S.pneumoniae causes

A
  • Otitis media
  • Pneumonia
  • Meningitis
  • Septicaemia

Biofilms

  • The role of biofilms in the ability of S. pneumoniae to persist at various sites of infection is not well understood, and their contribution to invasive disease remains controversial
  • Most studies of pneumococcal biofilms have been carried out in vitro, and in vivo data are limited
  • In biopsy samples from volunteers colonized in experimental human studies, S. pneumoniae was found in microcolonies

Ions

iron (Fe), manganese (Mn) and zinc (Zn), is crucial for growth and survival of S. pneumoniae in multiple host niches

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How do vaccines impact transmission disease and carriage?

A

Transmission

  • Indirect effects
  • Herd immunity
  • Dynamix flux
  • Confounders

Carriage:

  • Decrease in vaccine serotypes
    • You have immunity against some serotypes
  • Non vaccine type replacement
  • Co colonising species impact
  • New invasive species potential

Disease

  • Does not occur because of the vaccine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the importance of pneumococcal carriage?

A
  • Natural host reservoir
    • Staging post for onward transmission (to new hosts) or invasive disease
    • Pneumococcal biology evolved for colonisation
      • Virulence factors
    • Genetic exchange possible with other co-colonisers
  • Bill and Melinda Gates Foundation (BMGF) PneumoCarr Consortium: Case for Carriage
    • Modify serotypes and antibiotic resistance genes
      • Observe serotype replacement
    • Nasopharyngeal carriage is a precursor for disease
    • Direct and indirect effects of vaccination (herd immunity)
    • Endpoint in phase III vaccine trials (carriage vs pneumonia)
      • These are larger trials
    • Public health evaluation- serotype replacement
    • Measurement of vaccine efficiency against colonisation (VEcol)
    • Licensure pathway for new vaccines
17
Q

What are the typical carriage methods?

A
  1. NPS 1ml STGG
    1. Bacterial load
      1. Species qPCR
      2. Serotype qPCR
      3. Metagenomics
  2. Primary plate (selective and non selective)
    1. Co-colonisers
      1. Microbiology
      2. Typing antisera
      3. Serotype mPCR
  3. Purity Plate Selective
    1. Single isolate
      1. Typing antisera
      2. Serotype mPCR
      3. Whole genome sequencing (WGS)
18
Q

What are the current serotyping methods?

A
  • Serological tests
    • Latex agglutination
    • Quelling reaction
      • Laborious
    • Bead-based immunoassay
  • Molecular methods
    • Sequential multiplex PCR
    • MassTag PCR
  • Application
    • Typing of invasive isolates
    • Monitoring vaccine studies
  • With these, you can see what kind of serotypes are being circulated
19
Q

What is the effect of the pneumococcal vaccine on Invasive pneumococcal disease (IDP ) in the UK?

A

IPD PCV7 under 2 years

  • In the first graph, you see that it shows the cumulative frequency of notfications of invasive pneumococcal disease
  • Each line represents a year
  • Once the Prevenar 7 vaccine is introduced in 2006, there is a decrease in pneumococcal disease attributed to the serotypes that the vaccine covers

IPD PCV13 not PCV7 under 2 years

  • You can see that subsequent post vaccine years, you can see increase in disease caused by other serotypes not covered by the vaccine in 2010
20
Q

Describe the biosynthesis of capsular polysaccharides

A

Neucleotide sugar synthesis

link sugar to lipid carrier

Sequential linkage of sugars

transport acoross membrane

linkage of repeat units

mature capsule polysaccharide to cell surface

21
Q

What is molecular serotyping array?

HINT: IT IS ABOUT THE CAPSULE POLYSACCHARIDE virulence factor. How would you sequence it?

A
  • Capsule polysaccharide
    • Important virulence factor -vaccine development
    • Structural differebces (serotyping)
    • Encoded by cps gene cluster
  • Sequenced cps locus in 90 serotypes
    • Identifies homology groups by function
    • Varying degrees of similarly in loci
  • Microarray to detect cps gene contect
    • Method for molecular serotyping
    • vaccine studies- serotype switching
  • Gene content needed to produced capsule polysaccharide differences
  • Combination of genes-> you can see what the serotype is
22
Q

CASE STUDY: MAELA CAMP THAILAND (mother to infant carriage)

A
  • SMRU Thailand- Multiple serotype detection
    • 11.2% NPS by WHO protocol
    • 43.2% NPS by sweep latex aggglutination
    • 48.8% NPS by microarray
  • SMRU Thailan- summary
    • Common serotype in approx 95% NPS by all methods
    • WHO protocol underestimates multiple serotype carriage
    • Microarray identified greatest number of serotypes
  • Bill and Melinda gates foundation (PNEUCARRIAGE PROJECT)
    • Systematic evaluation of 20 serotyping methods available
    • specific focus on detection of multiple serotype carriage
    • microarray leading method- high specificity & sensitivity
23
Q

What is the PneuCarriage project?

A

Shows the surveillance of disease and vaccine impact

  • Pre-vaccine
    • Establish baseline burden of carriage and disease
    • Determine serotypes circulating in population causing Invasive pneumococcal disease (IDP)
    • Estimate preducted coverage and impact of vaccine
  • Post vaccine
    • Monitor impact on pneumonia and vaccine type IPD cases
    • Assess carriage and potential serotype replacement
    • investigate herd immunity in non-vaccinated individuals
  • Wider context
    • Cost effectiveness (QALYs) or quality adjusted life years
    • Comparison of dosing schedules and local logistics
      • Depending on packaging,there might be a case of the cold chain
24
Q

How did the public helath england (PHE) do IDP surveillance?

A

PHE routinely requires enhanced surveillance of IPD

All isolates administered should be referred to the reference laboratory

PHE routinely requires GPs and paediatricians to complete a surveillance questionnaire for all laboratory-confirmed IPD cases in under 5s to monitor the impact of the PCV13 vaccine

Results: FALL in disease caused by specific serotypes of PCV13

Compared to the pre-vaccine era of 2006, you can see the reports of IPD due to any other serotype not covered by the PCV13 vaccine

The serotypes increase up till 2020, because of the COVID-19 pandemic (less spread of S.pneumoniae)

25
Q

What is the role of the bill and melinda gates (BMGF) in investigating carriage?

A
  • WHO
    • Funded original sequencing of cps locus for 90 serotypes
    • working groups for recommending standard methodologies
      • protocol for serotyping
    • leadership on global health issues, research and policy (major coordination )
  • Gates Foundation: PneuCarriage II Project
    • Follow-on from PneuCarriage methods evaluation project
    • Rollout of microarray method to Australia and south Arica
    • Analysis of samples from studies in Fiji and South Africa
      • Rollout of global access
  • Gates Foundation
    • Vietnam vaccine studies ongoing-doding schedules
    • Laos, Mongolia, Pap new guinesa vaccine rollout studies
    • Malawi vaccine rollout- reservoirs for vaccine escape
      • Different antimicrobial properties are different between populations
26
Q

What were the results of the Fiji impact study?

A

65% reduction in PCV10 serotype carriage in 12-23m children (children are vaccinated, therefore herd immunity

Indirect effects in younger and older childrenplus caregivers

27
Q

What is the role of GAVI?

A
  • Funding and delivery of vaccine roll-out in developing countries
    • GAVI rollout pneumococcal vaccine to nearly 60 countries
    • Advance Market Commitment: right pric, quantity and time
    • Partnership of governments, NGOs, charities and companies